The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
914
January 21, 1994
View Complete Issue         Table of Contents 2019 
Piperacillin/Tazobactam
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Piperacillin/Tazobactam
January 21, 1994 (Issue: 914)
Piperacillin/tazobactam (Zosyn - Lederle), an antibiotic combination product, has been approved by the US Food and Drug Administration for intravenous treatment of intra-abdominal, pelvic, skin, and skin-structure infections and for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Piperacillin/Tazobactam
Article code: 914a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.